Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych MEQs / SAQsGeneral adult psychiatry — trauma and stressor-related

Psych MEQs / SAQs · General adult psychiatry — trauma and stressor-related

Adjustment disorders — diagnosis, risk and stepped care (MEQ)

FRANZCP-style MEQ on adjustment disorder after job loss: criteria vs MDD/PTSD, suicide risk nuance, brief interventions, selective pharmacotherapy, occupational activation, ICD-11 deltas.

20 marks20 min
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 41-year-old project manager is referred 8 weeks after compulsory redundancy. She describes tearfulness, anxiety about finances, initial insomnia and reduced socialising. She denies pervasive anhedonia or worthlessness most of the day. PHQ-9 is 9; GAD-7 is 11. She has intermittent passive thoughts that 'my family would be better without my stress' without plan or intent. She drinks three glasses of wine most evenings since the redundancy. No Criterion A trauma. TSH last year normal. (i) Outline diagnostic formulation including DSM timing rules and key differentials with discriminators. (ii) Detail risk assessment priorities and why the AD label does not lower risk standards. (iii) Outline a stepped management plan including watchful waiting criteria, brief psychological ingredients, and when you would name an antidepressant with dose and monitoring. (iv) Discuss occupational/return-to-work principles. (v) State ICD-11 contrast points examiners may ask. (20 marks)

Model answer

Reveal model answer

(i) Formulation and differentials. Working diagnosis: adjustment disorder with mixed anxiety and depressed mood, acute, following redundancy 8 weeks ago (onset well within the DSM 3-month window), with clinically significant distress/impairment, not meeting full MDE (no pervasive daily anhedonia/worthlessness pattern described; PHQ-9 9 is mild band monitoring, not diagnosis). Specifier and acute course stated. Differentials with discriminators: MDD (needs full episode criteria — recheck); GAD (needs multi-domain worry ≥6 months, not only post-redundancy); PTSD/ASD (no Criterion A trauma); normal stress reaction (impairment and disproportion argue clinical AD); substance-induced mood (alcohol contributing, not sole cause yet); medical (prior TSH normal; recheck if new features). Exclude dual-coding full MDD as AD.[1][6]

(ii) Risk. Expand passive burden thoughts: frequency, intent, plan, means, prior attempts, hopelessness, impulsivity, alcohol-related disinhibition, protective factors (children, future job search). Safety plan, means advice, crisis contacts, early review. Literature shows suicidality occurs in AD populations — including youth samples — so the AD label never justifies a truncated risk assessment.[2][6]

(iii) Stepped management. Psychoeducation on stress-response syndromes; reduce alcohol with motivational approach; sleep hygiene. If mild–moderate and engaged: brief problem-solving therapy (define financial/job problems, options, implement, review) plus brief CBT for catastrophic appraisals and behavioural activation; active monitoring with 2-week review if very mild and well supported.[4][6] Antidepressant not automatic. If symptoms intensify toward MDD, remain severe, or fail psychological care: example sertraline 25–50 mg orally daily, early review 1–2 weeks for activation/suicidality, titrate as tolerated, measurement-based PHQ-9/GAD-7, several weeks at therapeutic dose. Avoid long-term benzodiazepines as primary plan.[4][6]

(iv) Occupational principles. Early activation rather than indefinite sick certification without plan; graded return-to-work; address workplace barriers; evidence that activating interventions can reduce long-term sickness absence in AD.[3]

(v) ICD-11. Emphasise preoccupation with the stressor/consequences and failure to adapt; typical onset about 1 month; usually resolves within 6 months unless stressor continues — name system when quoting numbers.[5]

Common errors

  • Soft-labelling full MDD as AD because a stressor exists.
  • Skipping suicide assessment.
  • "Start an SSRI" with no indication hierarchy or dose.
  • Indefinite medical certificate without activation plan.
  • Confusing AD with ASD/PTSD timing and trauma criteria. [1][2]

Examiner notes

Full marks need operational DSM timing, discriminators, risk nuance, concrete brief-therapy ingredients, selective pharmacotherapy with a named dose when used, and occupational activation. [3][4]

References

  1. [1]Bachem R, Casey P Adjustment disorder: A diagnosis whose time has come J Affect Disord, 2018.PMID 29107817
  2. [2]Pelkonen M, Marttunen M, Henriksson M, Lönnqvist J Suicidality in adjustment disorder--clinical characteristics of adolescent outpatients Eur Child Adolesc Psychiatry, 2005.PMID 15959663
  3. [3]van der Klink JJ, Blonk RW, Schene AH, van Dijk FJ Reducing long term sickness absence by an activating intervention in adjustment disorders Occup Environ Med, 2003.PMID 12771395
  4. [4]Domhardt M, Baumeister H Psychotherapy of adjustment disorders: Current state and future directions World J Biol Psychiatry, 2018.PMID 30204563
  5. [5]Maercker A, Brewin CR, Bryant RA, Cloitre M, et al. Diagnosis and classification of disorders specifically associated with stress: proposals for ICD-11 World Psychiatry, 2013.PMID 24096776
  6. [6]Casey P Adjustment disorder: epidemiology, diagnosis and treatment CNS Drugs, 2009.PMID 19845414